Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiotensin II in Septic Acute Renal Failure (ASK-IT)
NCT00711789Phase 2Unknown
- Sponsor
- Austin Health
- Start
- Feb 2010
- Primary completion
- Feb 2013
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Angiotensin II in acute kidney injury (AKI) and septic shock (2 arms), sponsored by Austin Health. Primary endpoints: Urine output at 24 hours and Arterial blood pressure at 24 hours. Status: unknown.
02
Drugs
Angiotensin II
03
Conditions
acute kidney injury (AKI)septic shock
Beyond the preview
Go deeper on NCT00711789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00711789.